The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 09, 2020

Filed:

Dec. 18, 2015
Applicant:

Cellink Ab, Gothenburg, SE;

Inventor:

Paul Gatenholm, Riner, VA (US);

Assignee:

CELLINK AB, Gothenburg, SE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/20 (2006.01); B33Y 80/00 (2015.01); B33Y 70/00 (2015.01); C08L 1/02 (2006.01); C08B 15/08 (2006.01); B33Y 40/00 (2020.01); C09D 101/02 (2006.01); A61L 27/38 (2006.01); C09D 11/04 (2006.01); C09D 11/14 (2006.01); B82Y 5/00 (2011.01); B82Y 15/00 (2011.01); B29C 64/112 (2017.01); A61F 2/04 (2013.01); B29K 1/00 (2006.01); B29L 31/00 (2006.01);
U.S. Cl.
CPC ...
A61L 27/20 (2013.01); A61L 27/3817 (2013.01); A61L 27/3882 (2013.01); B33Y 40/00 (2014.12); B33Y 70/00 (2014.12); B33Y 80/00 (2014.12); C08B 15/08 (2013.01); C08L 1/02 (2013.01); C09D 11/04 (2013.01); C09D 11/14 (2013.01); C09D 101/02 (2013.01); A61F 2/04 (2013.01); A61F 2250/0081 (2013.01); A61L 2430/06 (2013.01); A61L 2430/34 (2013.01); B29C 64/112 (2017.08); B29K 2001/00 (2013.01); B29K 2089/00 (2013.01); B29K 2995/0056 (2013.01); B29L 2031/7532 (2013.01); B82Y 5/00 (2013.01); B82Y 15/00 (2013.01);
Abstract

The present invention relates to biomaterial in the form of dispersion of cellulose nanofibrils with extraordinary shear thinning properties which can be converted into desire 3D shape using 3D Bioprinting technology. In this invention cellulose nanofibril dispersion, is processed through different mechanical, enzymatic and chemical steps to yield dispersion with desired morphological and rheological properties to be used as bioink in 3D Bioprinter. The processes are followed by purification, adjusting of osmolarity of the material and sterilization to yield biomaterial which has cytocompatibility and can be combined with living cells. Cellulose nanofibrils can be produced by microbial process but can also be isolated from plant secondary or primary cell wall, animals such as tunicates, algae and fungi. The present invention describes applications of this novel cellulose nanofibrillar bioink for 3D Bioprinting of tissue and organs with desired architecture.


Find Patent Forward Citations

Loading…